Associate Professor, Pathology, Case Western Reserve University School of Medicine
Pathology
Dr. Wei Xin, MD
|
|
Give Review
practices Pathology. He researched medicine at Shanghai Medical University. Doctor Wei Xin, MD is also a published doctor. He has 8 paper published. The most recent paper is: IL-33 Interleukin-33 Drives Eosinophil Infiltration and Pathogenic Type 2 Helper T-Cell Immune Responses Leading to Chronic Experimental Ileitis. He accepts all Medicare patients.
Publications
- IL-33 Interleukin-33 Drives Eosinophil Infiltration and Pathogenic Type 2 Helper T-Cell Immune Responses Leading to Chronic Experimental Ileitis.
- CRABP-II is a highly sensitive and specific diagnostic molecular marker for pancreatic ductal adenocarcinoma in distinguishing from benign pancreatic conditions.
- Dysregulated NOD2 predisposes SAMP1/YitFc mice to chronic intestinal inflammation.
- Significance of Notch1-signaling pathway in human pancreatic development and carcinogenesis.
- Tregs are dysfunctional in vivo in a spontaneous murine model of Crohn's disease.
- Hepatic angiomyolipoma.
- Utilization of CDX2 Expression in Diagnosing Pancreatic Ductal Adenocarcinoma and Predicting Prognosis.
Doctors Specialties
- Pathology
Accepted Insurances
Education
-
University of Michigan Hospitals and Health Centers -
Shanghai Medical University
Hospital
-
University Hospitals Case Medical Center
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1730112269 |
| Last Name Of The Provider | XIN |
| First Name Of The Provider | WEI |
| View All |
Similar Doctors
|
|
Dr. Andrew J. Fishleder, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Terakeith Lertsburapa, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hong Hong, MD
This Doctor is OpenDoctor Recommended.
|